CD8A and neoplasm: Repeating this process 100 times we attain average pairwise classification accuracies: CD8+ vs. FoxP3+ 74.7%, CD8+ vs. CD68+ 65.3%, and FoxP3+ vs. CD68+ 86.3% (see tumor TC in SI Appendix, Table S10).